Gilead says Remedsvir shows improvement in COVID-19 patients when used.

0
111
Gilead says Remedsvir shows improvement in COVID-19 patients when used.
FILE PHOTO: An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues. Ulrich Perrey/File Photo

The company said Gilead Sciences Inc.’s experimental antiviral drug remedies helped improve symptoms in COVID-19 patients who had previously been treated.
In the past few weeks, the closely watched drugs have moved into the markets and on Wednesday, the broad markets have once again boosted figures and Gilead shares have also jumped 9%.

The company said that in Gilead’s study, 62% of patients were discharged from the hospital early, while 49% of patients were treated late.

The trial was testing 397 patients, evaluating the safety and efficacy of five-day and 10-day doses of Remedisvir in hospitalized patients with severe manifestations of COVID-19.